Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
8.13
-0.21 (-2.52%)
May 7, 2026, 2:08 PM EDT - Market open
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $238.87 million as of May 7, 2026. Its market cap has decreased by -18.11% in one year.
Market Cap
238.87M
Enterprise Value
127.38M
1-Year Change
-18.11%
Ranking
Category
Stock Price
$8.13
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $238.87M, an increase of 43.84%. That is a compound annual growth rate of 15.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 245.04M | 30.70% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 255.55M |
| Voyager Therapeutics | 248.53M |
| Fennec Pharmaceuticals | 247.53M |
| Heron Therapeutics | 247.12M |
| Codexis | 241.71M |
| Milestone Pharmaceuticals | 241.62M |
| Orchestra BioMed Holdings | 240.52M |
| Adagene | 239.18M |